See the DrugPatentWatch profile for cosentyx

Based on the available information, it is recommended to consult with a healthcare professional before receiving the MMR (measles, mumps, and rubella) vaccine right after taking Cosentyx (secukinumab) [1].

Cosentyx is a medication used to treat several types of inflammatory diseases, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [2]. It is a type of drug called a monoclonal antibody, which works by targeting a specific molecule in the body called interleukin-17A (IL-17A) [2].

The MMR vaccine is a live attenuated vaccine, which means it contains weakened viruses that stimulate an immune response in the body [3]. Live vaccines like MMR are generally not recommended for people taking medications that suppress the immune system, as they may not produce a sufficient immune response and could potentially lead to infection [3].

However, the decision to administer a live vaccine after taking Cosentyx should be made on a case-by-case basis, taking into account factors such as the patient's overall health, the duration since the last Cosentyx dose, and the potential risks and benefits of vaccination [1].

Therefore, it is crucial to consult with a healthcare professional before making any decisions regarding vaccination while taking Cosentyx [1].

Sources:

[1] Drugs.com. (2021). Secukinumab (Cosentyx) Drug Interactions - Drugs.com. Retrieved from <https://www.drugs.com/drug-interactions/secukinumab-cosentyx,immunization-vaccine,live-virus.html>

[2] Novartis. (2021). Cosentyx (secukinumab) [Prescribing Information]. Retrieved from <https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf>

[3] Centers for Disease Control and Prevention. (2021). Who Should NOT Get Certain Vaccines? Retrieved from <https://www.cdc.gov/vaccines/vpd/vpd-vac-table.html>

[4] DrugPatentWatch. (2021). Cosentyx (secukinumab) Drug Profile. Retrieved from <https://www.drugpatentwatch.com/drugs/cosentyx>